Gathering Records to Evaluate Antiretroviral Treatment-South Africa
GREAT
Analysis of Existing Medical Record Data to Evaluate Coverage, Uptake, Benefits, and Costs of Differentiated Models of Service Delivery for HIV Treatment in Africa (South Africa)
1 other identifier
observational
7,000,000
1 country
1
Brief Summary
To achieve global goals for the treatment of HIV, most high-prevalence countries are experimenting with and scaling up differentiated service delivery models (DSD). A handful of efforts have been formally described and evaluated in the literature; many others are being implemented formally or informally under routine care, without a research or evaluation goal. For most countries, however, we have little evidence on the big picture-the proportion of clinics offering alternative models, eligibility criteria and the proportion of patients considered eligible, the number of patients actually participating, health outcomes such as viral suppression, empirical resource utilization compared to traditional care, variations among the models, duration of patient participation, fidelity to model guidelines, effects on clinic efficiency, and sustainability without external donor support. AMBIT a set of data synthesis, data collection, and data analysis activities aimed at generating information for near- and long-term decision making and creating an approach and platform for ongoing evaluation of differentiated models of HIV treatment delivery in the future. The project will collect and analyze a wide range of existing data sets pertinent to DSD. This protocol is for an analysis of existing medical record data collected by the Department of Health, implementing partners, and other completed, ongoing, or new evaluations, trials, and observational studies. Outcomes to be reported include coverage/uptake of DSD, patients' outcomes, and distribution of each model. There will be no study interaction with individual patients, providers, caregivers, or others for this analysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 31, 2019
CompletedFirst Posted
Study publicly available on registry
November 4, 2019
CompletedStudy Start
First participant enrolled
December 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
November 17, 2025
November 1, 2025
7.1 years
October 31, 2019
November 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Patient-months enrolled in any DSD model
% of all patient-months of ART provided for the cohort that are provided within DSD models
12 months
Patient-months enrolled in any DSD model
% of all patient-months of ART provided for the cohort that are provided within DSD models
24 months
Patient-months enrolled in any DSD model
% of all patient-months of ART provided for the cohort that are provided within DSD models
6 months
Study Arms (2)
Patients enrolled in differentiated service delivery models
Patients not enrolled in DSD models
Interventions
The study will collect routine medical record data from the electronic medical record system, other electronic databases, and paper charts.
Eligibility Criteria
All adults who are accessing care for HIV anywhere in the country.
You may qualify if:
- ≥ 15 years old
- Patients accessing care for HIV within the data collection period
- In any HIV transmission risk group
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Boston Universitylead
- Bill and Melinda Gates Foundationcollaborator
- University of Witwatersrand, South Africacollaborator
Study Sites (1)
All clinics
Johannesburg, 2193, South Africa
Related Publications (1)
Huber AN, Jamieson L, Fox MP, Manganye M, Malala L, Chidarikire T, Khoza N, Nichols BE, Rosen S, Pascoe S. Evaluating the impact of differentiated service delivery (DSD) on retention in care and HIV viral suppression in South Africa: A target trial emulation using routine healthcare data. PLoS Med. 2025 Aug 26;22(8):e1004489. doi: 10.1371/journal.pmed.1004489. eCollection 2025 Aug.
PMID: 40857347DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Sydney B Rosen, MPA
Boston University School of Public Health, Global Health
- PRINCIPAL INVESTIGATOR
Matthew A Fox, DSc
Boston University School of Public Health, Global Health
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 31, 2019
First Posted
November 4, 2019
Study Start
December 1, 2019
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2027
Last Updated
November 17, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share